Judge questions difference between Hegseth’s testosterone policy and transgender care for troops
Headline from Federal News Network
U.S. District Judge Ana Reyes in Washington raised the question Wednesday in an ongoing lawsuit against President Donald Trump's ban on transgender troops.
Federal News Network's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
This story originally appeared on The Advocate . A federal judge has ordered the Pentagon to explain why testosterone treatment is being promoted as a readiness-enhancing benefit for some service members while the same hormone care is being used to justify removing transgender troops from the milita…
A federal judge suggested Wednesday that Defense Secretary Pete Hegseth's new policy requiring troops to meet testosterone levels -- and delivering testosterone replacement therapy -- could undercut the rationale behind the department's restrictions on trans troops.
U.S. District Judge Ana Reyes in Washington raised the question Wednesday in an ongoing lawsuit against President Donald Trump's ban on transgender troops.
WASHINGTON — Defense Secretary Pete Hegseth’s new initiative to test and treat troops for low testosterone has prompted a federal judge to question the differences between that kind of testosterone replacement therapy and hormone treatment for transgender men in the military.
“Secretary of War” and ultimate “alpha male” Pete Hegseth’s manly new policy promoting testosterone treatments to U.S. military servicemen over the age of 30 has been called into question by a federal judge who wants to know why certain people in the military are being offered gender-affirming care …
A federal judge is questioning whether the Pentagon’s new testosterone initiative undermines its legal defense of restrictions on transgender troops, ordering the government to explain why hormone treatment is acceptable for some service members yet disqualifying when provided for gender dysphoria.
A federal judge is asking how the Pentagon’s new screening program and hormone replacement therapy impact its justification for banning transgender servicemembers.
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
Judge questions difference between Hegseth’s testosterone policy and transgender care for troops | Since Then
